What is he best known for?
The fields of study he is best known for:
- Gene
- Immune system
- Cancer
His primary areas of study are Immunology, Cytotoxic T cell, Mucosal associated invariant T cell, Major histocompatibility complex and T cell.
His Immunology research includes themes of Cancer research and Cell biology.
Olivier Lantz has included themes like Antibody and CD8 in his Cytotoxic T cell study.
His studies in Mucosal associated invariant T cell integrate themes in fields like T lymphocyte and Interleukin 17, Cytokine.
His Major histocompatibility complex study which covers Microbiology that intersects with Virology, Virus, Minor histocompatibility antigen and Innate immune system.
His biological study spans a wide range of topics, including Dendritic cell, MHC class I, Gene rearrangement and Immunity.
His most cited work include:
- An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans. (927 citations)
- CD1 recognition by mouse NK1+ T lymphocytes (802 citations)
- CD1 recognition by mouse NK1+ T lymphocytes (802 citations)
What are the main themes of his work throughout his whole career to date?
Olivier Lantz mainly focuses on Immunology, T cell, Cytotoxic T cell, Mucosal associated invariant T cell and Antigen.
As part of his studies on Immunology, he often connects relevant subjects like Cell biology.
His T cell research is mostly focused on the topic T-cell receptor.
His Cytotoxic T cell study combines topics in areas such as T lymphocyte and CD8.
His CD8 study combines topics from a wide range of disciplines, such as Cancer research and Cellular differentiation.
His Mucosal associated invariant T cell research is multidisciplinary, relying on both Minor histocompatibility antigen, Antigen presentation and Microbiology.
He most often published in these fields:
- Immunology (51.81%)
- T cell (26.45%)
- Cytotoxic T cell (25.72%)
What were the highlights of his more recent work (between 2017-2021)?
- Cancer research (20.29%)
- T cell (26.45%)
- T-cell receptor (22.46%)
In recent papers he was focusing on the following fields of study:
Cancer research, T cell, T-cell receptor, Antigen and Immunology are his primary areas of study.
His study in Cancer research is interdisciplinary in nature, drawing from both Cell culture, CD8, Lymph node, Cytotoxic T cell and Lung cancer.
His T cell research focuses on Cellular differentiation and how it connects with RNA, Umbilical Cord Blood Transplantation and Cord blood.
His T-cell receptor research is multidisciplinary, incorporating elements of Natural killer T cell, Receptor, Molecular biology and Locus.
His specific area of interest is Antigen, where Olivier Lantz studies Major histocompatibility complex.
His study in Immunology is interdisciplinary in nature, drawing from both Transcriptome and Chronic stress.
Between 2017 and 2021, his most popular works were:
- Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition) (345 citations)
- Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells (322 citations)
- Natural variation in the parameters of innate immune cells is preferentially driven by genetic factors. (101 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Cancer
- Immune system
His main research concerns Cancer research, T cell, Antigen, Immunology and Immunity.
His study looks at the intersection of Cancer research and topics like Cytotoxic T cell with CD8, Monalizumab and Cetuximab.
Olivier Lantz is involved in the study of T cell that focuses on Mucosal associated invariant T cell in particular.
Olivier Lantz studies Major histocompatibility complex which is a part of Antigen.
In his study, Adjuvant is strongly linked to Cell culture, which falls under the umbrella field of Major histocompatibility complex.
His biological study spans a wide range of topics, including Transcriptome, Organ Specificity and Transgene.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
